Cefic-lri Programme | European Chemical Industry Council

18th Annual Cefic-LRI Workshop

The 18th Annual Cefic-LRI Workshop will take place in Brussels from 16-17 November 2016. The event is organised by the Long-Range Research Initiative Programme (LRI) of the European Chemical Industry Council (Cefic) and its main focus this year will be on ‘AOPs (Adverse Outcome Pathways) and Genomics: how useful, how to address risk, and where next?’

The event kicks off on the evening of Wednesday 16 November 2016 at the Le Plaza Hotel with an invited poster session and networking cocktail followed by a Red Carpet Gala Dinner and the 2016 LRI Innovative Science Award ceremony.

This evening session will be chaired by Nicolas Cudre-Mauroux from Solvay Award. He will introduce 2015 LRI award winner Dr Alice Limonciel of Innsbruck Medical University who will present the results of her study to establish thresholds of activation for stress response pathways and ligand-activated receptors for chemical classification.

This will be followed by the presentation of the €100,000 2016 LRI Innovative Science Award to the winning research concept who will outline the work they intend to undertake thanks to the award funding.

On Thursday, 17 November the workshop venue will be The Square in Brussels. This main workshop session will consist of a morning plenary session covering the impact of LRI research in the following key project areas:

  • Environmental methodology of mixtures and residues
  • Grouping of nanomaterials
  • Dust and workers exposure
  • Dermal absorption modelling
  • Eye irritation alternatives
  • Epidemiological evidence of Endocrine Disruption
  • Epigenetics normality

After Lunch a thematic panel discussion on ‘AOP and Genomics: how useful, how to address risk, and where next?’ will be chaired and moderated by Prof Ian Kimber of the University of Manchester.

You can download a draft programme for the event here!

 

Cefic-Lri Programme Responsible Care

© Copyright 2017 Cefic | European Chemical Industry Council. All rights reserved | Terms and Conditions of Use